Skip to Main content Skip to Navigation
Journal articles

A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Abstract : Fy blood group antigens are carried by the Duffy antigen receptor for chemokines (DARC), a red cells receptor for Plasmodium vivax broadly implicated in human health and diseases. Recombinant VHHs, or nanobodies, the smallest intact antigen binding fragment derivative from the heavy chain-only antibodies present in camelids, were prepared from a dromedary immunized against DARC N-terminal extracellular domain and selected for DARC binding. A described VHH, CA52, does recognize native DARC on cells. It inhibits P. vivax invasion of erythrocytes and displaces interleukin-8 bound to DARC. The targeted epitope overlaps the well-defined DARC Fy6 epitope. K (D) of CA52-DARC equilibrium is sub-nanomolar, hence ideal to develop diagnostic or therapeutic compounds. Immunocapture by immobilized CA52 yielded highly purified DARC from engineered K562 cells. This first report on a VHH with specificity for a red blood cell protein exemplifies VHHs' potentialities to target, to purify, and to modulate the function of cellular markers.
Complete list of metadatas

Cited literature [10 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00512838
Contributor : Alexandre G. de Brevern <>
Submitted on : Tuesday, August 31, 2010 - 5:05:51 PM
Last modification on : Thursday, June 4, 2020 - 11:46:02 AM
Long-term archiving on: : Thursday, December 1, 2016 - 3:26:16 PM

Identifiers

Citation

Dorota Smolarek, Claude Hattab, Gholamreza Hassanzadeh-Ghassabeh, Sylvie Cochet, Carlos Gutiérrez, et al.. A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.. Cellular and Molecular Life Sciences, Springer Verlag, 2010, 67 (19), pp.3371-87. ⟨10.1007/s00018-010-0387-6⟩. ⟨inserm-00512838⟩

Share

Metrics

Record views

611

Files downloads

3394